Prognostication of Brain-Metastasized Patients Receiving Subsequent Systemic Therapy: A Single-Center Long-Term Follow-Up
Background. Survival of patients with brain metastases (BMs) is poor. It has become clear that targeted therapy has an effect on BMs and patient’ prognosis. The question remains which patients benefit from additional systemic therapy. This assumption was evaluated in a large single-center cohort. Me...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-01-01
|
| Series: | Current Oncology |
| Subjects: | |
| Online Access: | https://www.mdpi.com/1718-7729/32/2/74 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Be the first to leave a comment!